Structure of Plasmodium falciparum liver stage antigen-1.
about
Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine DevelopmentDisruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasitesComplex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell AntigensCytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya.Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmidsProcess development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparumA prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayInterleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum.Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase.Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum.Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic.Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.Malaria vaccine development.Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNATranscriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicityImmune Responses in Malaria.Research note: HLA degenerate T-cell epitopes from Plasmodium falciparum liver stage-specific antigen 1 (LSA-1) are highly conserved in isolates from geographically distinct areas.HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT.Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria.Heterologous gene expression in bacterial systems under reduced oxygen tensions. Small-scale optimization precedes industrial fermentation.Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1-4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies.Development of a high-throughput flexible quantitative suspension array assay for IgG against multiple Plasmodium falciparum antigens.Analysis of factors affecting the variability of a quantitative suspension bead array assay measuring IgG to multiple Plasmodium antigens
P2860
Q27972709-A0EF8649-9367-4F2F-BCB9-517B7D094EF2Q27974558-2B70BA45-A870-4464-AC2B-8CA8747D386BQ28551311-D45B722F-8FFA-4EC8-91C6-7B1F26D6F609Q33599649-031DD2C2-BC61-43DD-8C06-94A02AF69E1BQ33761524-F2995F57-BA61-4741-992A-185B63373596Q33769381-9F1D10D9-21A3-4926-BD4C-8880006FB9FEQ33859633-FA008187-C488-4FDC-9A43-B53A688AFBC5Q33876788-AA4C349B-E23E-4C58-ACB7-BAFAD18DD2A1Q34002992-EE8D3C94-6A30-4C78-95BB-4CE96146233DQ34008562-3D33015A-232D-4BDE-A0B8-63CDCA559E95Q34567297-1541BD47-92A9-4A54-B7A2-5729B8BFFAFEQ34573891-704A52F8-841D-4F7C-A884-76ECB683AF8EQ34604206-04DD527B-B877-4163-9BFB-B88D3E03F9F1Q35021277-0C9F95A6-4E8F-49C6-AC7C-4210B06C25B2Q35439859-0555E88F-E2CD-4FB9-B003-8B1D0482A9D1Q35519418-F359F5CA-DEA8-4CCD-B011-CA8DF95D29AAQ35560038-5EF3AFCA-A385-4838-A6C5-165F4F42CB06Q36285998-E2079E5C-05E0-47E6-A553-33D49AD39FA0Q36641624-785083B1-2AAD-4A2C-8469-B40B53D150C9Q36694820-83B7072C-2843-4CED-88E4-14DD7DE29430Q37235262-8266E50F-9C9B-4006-8BD1-7BFB28EDA2E3Q40259888-962AA76A-E498-48D0-B77A-D46D25F40A5AQ46682166-B9C29328-ED19-4698-936F-8B7BD9D3F565Q47872316-F7373546-3DB4-4E2F-9457-955D771CFAECQ47875788-386FD27C-A14B-4C79-96B1-7DA2370BA8B4Q50115701-F86F132B-81B8-436B-AD9D-F132DF62A74AQ55292950-89171078-3505-4DD1-B458-91C312AA243CQ55342398-480E7EA1-17B6-4053-99EE-CFB0F91DCEE3Q56368212-74290389-B1EB-44A2-93E7-C463100410CA
P2860
Structure of Plasmodium falciparum liver stage antigen-1.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Structure of Plasmodium falciparum liver stage antigen-1.
@en
Structure of Plasmodium falciparum liver stage antigen-1.
@nl
type
label
Structure of Plasmodium falciparum liver stage antigen-1.
@en
Structure of Plasmodium falciparum liver stage antigen-1.
@nl
prefLabel
Structure of Plasmodium falciparum liver stage antigen-1.
@en
Structure of Plasmodium falciparum liver stage antigen-1.
@nl
P1476
Structure of Plasmodium falciparum liver stage antigen-1.
@en
P2093
P304
P356
10.1016/0166-6851(91)90117-O
P577
1991-10-01T00:00:00Z